Advagene Biopharma Co., Ltd. (TPEX:6709)
24.45
+0.65 (2.73%)
Sep 15, 2026, 1:29 PM CST
| Market Cap | 1.08B -39.7% |
| Revenue (ttm) | n/a |
| Net Income | -91.05M |
| EPS | -1.52 |
| Shares Out | 44.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,102 |
| Open | 24.30 |
| Previous Close | 23.80 |
| Day's Range | 23.60 - 24.45 |
| 52-Week Range | 22.50 - 41.00 |
| Beta | 0.67 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |